# A Study of Nivolumab in Patients With Head and Neck Cancer.

> **NCT04050761** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 502 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

## Interventions

- **BIOLOGICAL:** Nivolumab

## Key facts

- **NCT ID:** NCT04050761
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-26
- **Primary completion:** 2024-07-08
- **Final completion:** 2024-07-08
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050761, "A Study of Nivolumab in Patients With Head and Neck Cancer.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04050761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*